BIRC2
BIRC2 (baculoviral IAP repeat containing 2, also known as cIAP1, c-IAP1, hiap-2, MIHB, RNF48 and API1) is a multi-functional member of the IAP family. It acts as an E3 ubiquitin-protein ligase that regulates apoptosis, NF-kappa-B signalling and innate immunity. Browse Assay Genie's current range of BIRC2 research reagents below, or read on for the biology behind the target.
BIRC2 is a multi-functional protein that regulates caspases and apoptosis, but also modulates inflammatory signalling and immunity, mitogenic kinase signalling, cell proliferation, and cell invasion and metastasis. As an E3 ubiquitin-protein ligase it regulates NF-kappa-B signalling in opposite directions: it is a positive regulator of the canonical pathway and suppresses constitutive activation of the non-canonical pathway. Its ubiquitin ligase targets include RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, TRAF2, DIABLO/SMAC, MAP3K14/NIK, MAP3K5/ASK1, IKBKG/NEMO, IKBKE and MXD1/MAD1.
BIRC2 can also act as an E3 ligase of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. It is an important regulator of innate immune signalling through Toll-like receptors, Nod-like receptors and RIG-I like receptors, collectively termed pattern recognition receptors. By ubiquitinating RIPK1 and CASP8, it suppresses formation of the ripoptosome, a large multi-protein complex able to kill cancer cells in caspase-dependent and caspase-independent ways. It can also stimulate the transcriptional activity of E2F1 and plays a role in modulating the cell cycle.
The BIRC2 gene encodes a member of the IAP family, which inhibits apoptosis by binding the tumour necrosis factor receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. The protein inhibits apoptosis induced by serum deprivation and menadione, a potent inducer of free radicals. Alternatively spliced transcript variants encoding different isoforms have been described. HGNC places BIRC2 among the RING finger E3 ubiquitin protein ligases, the baculoviral IAP repeat containing group and the caspase recruitment domain containing proteins. The mouse ortholog is Birc2.
BIRC2 regulates caspases and restrains ripoptosome formation by ubiquitinating RIPK1 and CASP8, making it central to studies of cell death control.
BIRC2 positively regulates canonical NF-kappa-B signalling while suppressing constitutive non-canonical activation, so it is used to dissect how the two arms are balanced.
BIRC2 regulates Toll-like, Nod-like and RIG-I like receptor signalling, linking ubiquitination to pattern recognition receptor responses.
BIRC2 influences cell proliferation, invasion and metastasis, and protects cells from ripoptosome-mediated killing of cancer cells.
BIRC2 is an E3 ubiquitin-protein ligase that regulates apoptosis, inflammatory signalling and immunity. It promotes canonical NF-kappa-B signalling, suppresses non-canonical activation, and ubiquitinates targets such as RIPK1 and CASP8 to prevent ripoptosome formation. It can also neddylate effector caspases, inactivating them.
BIRC2 is also called cIAP1, c-IAP1, hiap-2, MIHB, RNF48 and API1. The HGNC name is baculoviral IAP repeat containing 2. Alternatively spliced transcript variants encoding different isoforms have been reported, so check the datasheet of any product for its validated reactivity.
BIRC2 belongs to the IAP family and to the HGNC group of baculoviral IAP repeat containing RING finger E3 ligases. The mouse ortholog is Birc2. Related family members with their own pages include BIRC3, BIRC6 and BIRC7.
Other baculoviral IAP repeat containing proteins and related apoptosis and NF-kappa-B regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13490; product specifications from Assay Genie datasheets.